OCULOMOTOR DEFICITS IN PREMANIFEST AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES: THE LONGITUDINAL TRACK-HD STUDY

OCULOMOTOR DEFICITS IN PREMANIFEST AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES: THE LONGITUDINAL TRACK-HD STUDY

Detalhes bibliográficos
Principais autores:	Hicks, S, Scahill, R, Dumas, E, Durr, A, Blair, R, Levitt, B, Roos, R, Tabrizi, S, Kennard, C
Formato:	Conference item
Publicado em:	2012

Registros relacionados

OCULOMOTOR DEFICITS IN PRESYMPTOMATIC AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES
por: Hicks, S, et al.
Publicado em: (2010)

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
por: Tabrizi, S, et al.
Publicado em: (2011)

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
por: Tabrizi, S, et al.
Publicado em: (2012)

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
por: Tabrizi, S, et al.
Publicado em: (2011)

SIGNIFICANT BIOLOGICAL AND CLINICAL CHANGE DETECTED OVER 1 YEAR IN PREMANIFEST AND EARLY STAGE HUNTINGTON'S DISEASE IN THE TRACK-HD STUDY
por: Tabrizi, S, et al.
Publicado em: (2010)

SIGNIFICANT BIOLOGICAL AND CLINICAL CHANGE DETECTED OVER 1 YEAR IN PREMANIFEST AND EARLY STAGE HUNTINGTON'S DISEASE IN THE TRACK-HD STUDY
por: Tabrizi, S, et al.
Publicado em: (2010)

Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice.
por: Jessica Y Winder, et al.
Publicado em: (2018-01-01)

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
por: Scahill, R, et al.
Publicado em: (2013)

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy
por: Scahill, R, et al.
Publicado em: (2013)

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
por: Tabrizi, S, et al.
Publicado em: (2009)

Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.
por: Dumas, E, et al.
Publicado em: (2012)

Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease
por: Dumas, E, et al.
Publicado em: (2011)

QUANTITATIVE ASSESSMENT OF BIOLOGICAL AND CLINICAL MANIFESTATIONS OF HUNTINGTON'S DISEASE BEFORE AND AFTER DIAGNOSIS-THE TRACK-HD STUDY
por: Lahiri, N, et al.
Publicado em: (2010)

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
por: Juan F Domínguez D, et al.
Publicado em: (2013-01-01)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Stefan Klöppel, et al.
Publicado em: (2015-10-01)

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
por: Paul Zeun, et al.
Publicado em: (2022-01-01)

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
por: Marios Politis, et al.
Publicado em: (2015-11-01)

The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington’s disease individuals
por: Filipa Júlio, et al.
Publicado em: (2019-11-01)

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
por: Nicola Pavese, et al.
Publicado em: (2010-02-01)

Lumbar puncture safety and tolerability in premanifest and manifest Huntington’s disease: a multi-analysis cross-sectional study
por: Yara Refaat Hassan, et al.
Publicado em: (2022-11-01)

Huntington disease: from premanifest to diagnosis and early care
por: Elizabeth A McCusker
Publicado em: (2019-01-01)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Beatrice Heim, et al.
Publicado em: (2020-11-01)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: Giulia D’Aurizio, et al.
Publicado em: (2019-04-01)

Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation.
por: Lauren M Turner, et al.
Publicado em: (2015-01-01)

Altered Intracortical T1-Weighted/T2-Weighted Ratio Signal in Huntington’s Disease
por: Christopher D. Rowley, et al.
Publicado em: (2018-11-01)

Corrigendum to “Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers” [Neurobiol. Dis. 83 (2015) 115–121]
por: Marios Politis, et al.
Publicado em: (2017-02-01)

Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease
por: Eduardo Castro, et al.
Publicado em: (2018-01-01)

Linking white matter and deep gray matter alterations in premanifest Huntington disease
por: Andreia V. Faria, et al.
Publicado em: (2016-01-01)

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease
por: Lora Minkova, et al.
Publicado em: (2018-01-01)

Diffusion MRI in premanifest Huntington's disease and early Parkinson's disease: tensor and tractography analyses
por: Pflanz, C
Publicado em: (2019)

Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease
por: Marina Herrero‐Lorenzo, et al.
Publicado em: (2024-10-01)

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
por: Travis Cruickshank, et al.
Publicado em: (2021-03-01)

The relationship between non-motor features and weight-loss in the premanifest stage of Huntington's disease.
por: Wasiq Khan, et al.
Publicado em: (2021-01-01)

Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease
por: Danielle M. Bartlett, et al.
Publicado em: (2019-01-01)

Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study
por: Govinda R. Poudel, et al.
Publicado em: (2015-02-01)

Associations between Sleep Quality and Serum Levels of Neurofilament Light in Individuals with Premanifest Huntington Disease
por: Mitchell Turner, et al.
Publicado em: (2024-06-01)

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing
por: Elizabeth A. McCusker, et al.
Publicado em: (2017-09-01)

Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington’s Disease
por: Eileanoir B. Johnson, et al.
Publicado em: (2017-10-01)

A computational cognitive biomarker for early-stage Huntington's disease
por: Wiecki, T, et al.
Publicado em: (2016)

Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington’s disease
por: Beini Hu, et al.
Publicado em: (2023-01-01)